Content Preview
Newsday 7 day/Optimum Online® subscribers click here for full access
Not a Newsday or Optimum Online® subscriber? Click here
Biogen raises Facet offer to $17.50 per share
Quick ReadBiogen Idec says it is raising unsolicited offer for Facet Biotech offer to $493M from $356M
NEW YORK (AP) — Biogen Idec Inc. said Thursday it raised its offer for Facet Biotech Corp. to $17.50 per share from $14.50 per share, valuing Facet at a total of $493 million.
The new price, which Biogen called its "best and final offer," represents a premium of almost 25 percent to Facet's Thursday closing price and is nearly double Facet's stock price on Sept. 2 — the day before Biogen made...
Newsday & ExploreLI are now available at no charge to Newsday 7-day and Optimum Online® subscribers. To continue reading, please log in or register now.
